Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 2 | Cell & Bioscience

Fig. 2

From: Ferulic acid combined with aspirin demonstrates chemopreventive potential towards pancreatic cancer when delivered using chitosan-coated solid-lipid nanoparticles

Fig. 2

Dose dependent inhibition of cell viability in pancreatic cancer cells. a, c MIA PaCa-2 and b, d Panc-1 cells were treated with unmodified ferulic acid (FA), unmodified aspirin (ASP), FA encapsulated in chitosan-solid lipid nanoparticles (c-SLNs), and ASP c-SLNs. MTS assay was performed to determine the cell viability of MIA PaCa-2 and Panc-1 cells after treating with a range of concentrations of free and c-SLN modified FA and ASP for 72 h. The IC50 values were then determined using nonlinear regression using graph pad prism software. Each data point represents the mean percent viable cells measured in three parallel but independent experiments

Back to article page